Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stenmark, K. R.
Right arrow Articles by Das, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stenmark, K. R.
Right arrow Articles by Das, M.
(Chest. 2002;122:326S-334S.)
© 2002 American College of Chest Physicians

Hypoxic Activation of Adventitial Fibroblasts*

Role in Vascular Remodeling

Kurt R. Stenmark, MD; Evgenia Gerasimovskaya, PhD; Raphael A. Nemenoff, PhD and Mita Das, PhD

* From the Developmental Lung Biology Research Laboratory, University of Colorado Health Sciences Center, Denver, CO.

Correspondence to: Kurt R. Stenmark, MD, Professor of Pediatrics, Head, Pediatric Critical Care Medicine, and Developmental Lung Biology Laboratory, University of Colorado Health Sciences Center, 4200 E Ninth Ave, Box B131, Denver, CO 80262; e-mail: Kurt.Stenmark{at}UCHSC.edu

Substantial experimental evidence supports the idea that the fibroblast may play a significant role in the vascular response to injury, especially under hypoxic conditions. Fibroblasts have the ability to rapidly respond to hypoxic stress and to modulate their function to adapt rapidly to local vascular needs. Fibroblasts appear to be uniquely equipped to proliferate, transdifferentiate, and migrate under hypoxic conditions. Proliferative responses to hypoxia depend on the activation of G{alpha}i and Gq kinase family members, and on the subsequent stimulation of protein kinase C and mitogen-activated protein kinase family members. Extracellular nucleotides (eg, adenosine triphosphate [ATP]) are likely to be increased in the hypoxic adventitial compartment and can act as autocrine/paracrine modifiers of the hypoxia-induced proliferative response. The proliferative effects of ATP appear to be mediated largely through G-protein-coupled P2Y receptors in fetal and neonatal fibroblasts. Hypoxia, acting through G{alpha}{iota}-coupled pathways, also can directly up-regulate {alpha}-smooth muscle actin expression in fibroblast subpopulations, suggesting that hypoxia may play a direct role in mediating the "transdifferentiation" of fibroblasts into myofibroblasts in the vessel wall. In addition, chronic hypoxia causes stable (at least in vitro) phenotypic changes in fibroblasts that appear to be associated with changes in the signaling pathways used to elicit proliferation. However, it is also becoming clear that, similar to the heterogeneity described for vascular smooth muscle cells, numerous fibroblast subtypes exist in the vessel wall, and that each may respond in unique ways to hypoxia and other stimuli and thus serve special functions in response to injury. In fact, adventitia may be considered to be compartments in which cells with "stem-cell-like" characteristics reside. Future work is needed to determine more precisely the role of the fibroblast in the wide variety of vascular complications observed in many humans diseases, and in the genes and gene products that confer unique properties to this important vascular cell.

Key Words: adenosine triphosphate • extracellular nucleotides • fibroblast • growth • hypoxia • mitogen-activated protein kinases • myofibroblast • protein kinase C • transdifferentiation • vascular development




This article has been cited by other articles:


Home page
Eur Respir JHome page
M. C. Tamby, M. Humbert, P. Guilpain, A. Servettaz, N. Dupin, J. J. Christner, G. Simonneau, J. Fermanian, B. Weill, L. Guillevin, et al.
Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension
Eur. Respir. J., October 1, 2006; 28(4): 799 - 807.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. F. Banks, E. V. Gerasimovskaya, D. A. Tucker, M. G. Frid, T. C. Carpenter, and K. R. Stenmark
Egr-1 antisense oligonucleotides inhibit hypoxia-induced proliferation of pulmonary artery adventitial fibroblasts
J Appl Physiol, February 1, 2005; 98(2): 732 - 738.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
H. Zhong, L. Belardinelli, T. Maa, and D. Zeng
Synergy between A2B Adenosine Receptors and Hypoxia in Activating Human Lung Fibroblasts
Am. J. Respir. Cell Mol. Biol., January 1, 2005; 32(1): 2 - 8.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. G. Kallapur, C. J. Bachurski, T. D. L. Cras, S. N. Joshi, M. Ikegami, and A. H. Jobe
Vascular changes after intra-amniotic endotoxin in preterm lamb lungs
Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1178 - L1185.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
G. J. Hausman and R. L. Richardson
Adipose tissue angiogenesis
J Anim Sci, March 1, 2004; 82(3): 925 - 934.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
N. B. Halasa, F. E. Barr, J. E. Johnson, and K. M. Edwards
Fatal Pulmonary Hypertension Associated With Pertussis in Infants: Does Extracorporeal Membrane Oxygenation Have a Role?
Pediatrics, December 1, 2003; 112(6): 1274 - 1278.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American College of Chest Physicians.